Riluzole improves functional recovery after ischemia in the rat retina

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 3, 1999, Pages 729-736

  Ettaiche, Mohamed ^a   Fillacier, Kathleen ^a   Widmann, Catherine ^a   Heurteaux, Catherine ^a   Lazdunski, Michel ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RILUZOLE;

A WAVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B WAVE; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; DNA NICK TRANSLATION; DRUG EFFECT; ELECTRORETINOGRAPHY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINA DEGENERATION; RETINA ISCHEMIA;

ADMINISTRATION, TOPICAL; ANIMALS; APOPTOSIS; ELECTRORETINOGRAPHY; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INJECTIONS; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, INBRED BN; REPERFUSION INJURY; RETINA; RETINAL DEGENERATION; RETINAL VESSELS; RILUZOLE;

EID: 0032978491     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Massey SC. Cell types using glutamate as a neurotransmitter in the vertebrate retina. In: Osborne NN, Chader GJ, eds. Progress in Retinal Research. Oxford, UK: Pergamon Press; 1990:400-420.
2. Barnstable CJ. Glutamate and GABA in retinal circuitry. Curr Opin Neurobiol. 1993;3:520-525.
3. Kalloniatis M. Amino acids in neurotransmission and disease. J Am Optom Assoc. 1995;66:750-757.
4. Pourcho RG. Neurotransmitters in the retina. Curr Eye Res. 1996; 15:797-803.
5. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. Am Med Arch Ophthalmol. 1957; 58:193-201.
6. Louzada-Junior P, Dias JJ, Santos WF, et al. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J Neurochem. 1992;59:358-363.
7. Neal MJ, Cunningham JR, Hutson PH, et al. Effects of ischaemia on neurotransmitter release from the isolated retina. J Neurochem. 1994;62:1025-103.3.
8. Dreyer EB, Zurakowski D, Schumer RA, et al. Elevated glutamate in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305
9. Mosinger JL, Price MT, Bai HY, et al. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol. 1991;113:10-17.
10. Zeevalk GD, Hyndman AG, Nicklas WJ. Excitatory amino acid-induced toxicity in chick retina: amino acid release, histology, and effects of chloride channel blockers. J Neurochem. 1989;53:1610-1619.
11. Benoit E, Escande D. Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pfluegers Arch. 1991;419:603-609.
12. Hebert T, Drapeau P, Pradier L, et al. Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Mol Pharmacol. 1994;45:1055-1060.
13. + channel activated by arachidonic acid and polyunsaturated fatty acids. EMBO J. 1998;17:3297-3308.
14. Cheramy A, Barbeiro L, Godeheu G, et al. Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett. 1992;147:209-212.
15. Martin D, Thompson MA, Nadler JV. The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area. Eur J Pharmacol. 1993;250:473-476.
16. Bensimon G, Lacomblez L. Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330: 585-591.
17. Lacomblez L, Bensimon G, Leigh PN, et al. For the ALS/Riluzole Study Group, II: Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet. 1996;347:1425-1431.
18. Pratt J, Rataud J, Bardot F, et al. Neuroprotective actions of ziluzole in rodent models of global and focal cerebral ischemia. Neurosci Lett. 1992;140:225-230.
19. Wahl F, Allix M, Plokine M, et al. Effect of riluzole on focal cerebral ischemia in rats. Eur J Pharmacol. 1993;230:209-214.
20. Stutzmann JM, Pratt J, Boraud T, et al. The effect of riluzole on post traumatic spinal cord injury in the rat. Neuroreport 1996;7:387-392.
21. Gallyas F, Güldner FH, Zoltay G, et al. Golgi-like demonstration of "dark" neurons with an argyrophil III method for experimental neuropathology. Acta Neuropathol. 1990;79:620-628.
22. Gavrieli Y, Sherman Y, Ben-Sason SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;11:493-501.
23. Founds WS, Johnson NF. Rabbit electroretinogram during recovery from induced ischaemia. Trans Ophthalmol Soc. 1974;94:383-393.
24. Eisenfeld AJ, Bunt-Milam AH, Sarthy PV. Müller cell expression of glial fibrillary acidic protein after genetic and experimental photoreceptor degeneration in the rat retina. Invest Ophthalmol Vis Sci. 1984;25:1321-1328.
25. Erickson PA, Fisher SK, Guerin CJ, et al. Glial fibrillary acidic protein increased in Müller cell after retinal detachment. Exp Eye Res. 1987;44:37-48.
26. Barnett NL, Osborne NN. Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to the rat retina without causing histological damage. Exp Eye Res. 1995;61:83-90.
27. Osborne NN, Larsen AK. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure: effect of glutamate antagonists. Neurochem Int. 1996; 29:263-270.
28. Choi DW. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol. 1996;6:667-672.
29. Büchi ER. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study, I: Ganglion cell layer and inner nuclear layer. Exp Eye Res. 19925;5: 605-613.
30. Büchi ER. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. II: Outer nuclear layer. Jpn J Ophthatmol. 1992;36:62-68.
31. Cook B, Lewis GP, Fisher S, et al. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci. 1995;36:990-996.
32. Quigley HA, Nickells RW, Kerrigan LA, et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
33. Mizoukami Y, Yoshioka K, Morimoto S, et al. A novel mechanism of JNK1 activation. J Biol Chem. 1997;272:16657-16662.
34. Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996;380:75-79.
35. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270:1326-1331.
36. Wyllie A, Kerr J, Currie A. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-305.
37. Fjell J, Dib-Hajj S, Fried K, et al. Differential expression of sodium channel genes in retinal ganglion cells. Mol Brain Res. 1997;50: 197-204.
38. Miguel-Hidalgo JJ, Snider CJ, Angelides KJ, et al. Voltage-dependent sodium channel alpha subunit immunoreactivity is expressed by distinct cell types of the cat and monkey retina. Vis Neurosci. 1994;11:219-228.
39. 3H) aspartate release from cultured cerebellar granule cells. Neurosci Lett. 1989; 96:345-350.
40. Girdlestone D, Dupuy A, Roy-Contensin L, et al. Riluzole antagonizes excitatory amino-acid evoked firing in rat facial motoneurons in vivo (Abstract). Br J Pharmacol. 1989;97:583P.
41. Debono MW, Le Guern J, Canton T, et al. Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur J Pharmacol. 1993; 235:283-289.
42. MacDonald JF, Nowak LM. Mechanisms of blockade of excitatory amino acid receptor channels. Trends Pharmacol Sci. 1990;11: 167-72.
43. Estevez AG, Stutzmann JM, Harbcito L. Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur J Pharmacol. 1995;280:47-53.